AtriCure Sells 5,000 Shares: Insider Move or Pattern Worth Watching?
A senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
Assess top-performing Hyd etfs for retirees, comparing yields, risk, and track records to help you choose a fund aligned with retirement goals.
27,995 articlesA senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
The kiplinger letter spots trap emerges as a focal point in retirement planning as 401(K) plans weigh adding private ...
Marvell Technology shares surprised investors with a notable intraday uptick amid improving sentiment for semiconduct...
The S&P 500 has momentum, but not every stock is priced to perfection. These dividend stocks stand out for income...
As AI accelerates, the question on many investors' minds is will Nvidia stock soar. This article breaks down the driv...
July can be a pivotal moment for travel stocks. Here are three clear reasons why Carnival stock may deserve a place o...
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
NVIDIA just delivered spectacular quarterly results that surpassed expectations and reinforced its leadership in AI c...
In May 2026, a Pizza Hut franchisee filed a Texas court lawsuit alleging Dragontail AI caused cascading operational b...
Micron reports robust Q3 guidance and signs a five-year strategic deal, fueling optimism that the AI memory cycle cou...
Markets are buzzing about a downturn, but the latest data suggests reacting to headlines may hurt more than help. Thi...
A wave of upgrades is reshaping Near Protocol. Privacy features, AI-ready smart contracts, and scaling improvements c...